- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 5/097 - Tripeptides the first amino acid being heterocyclic, e.g. Pro, His, Trp, e.g. thyroliberin, melanostatin
Patent holdings for IPC class C07K 5/097
Total number of patents in this class: 231
10-year publication summary
|
29
|
27
|
30
|
17
|
21
|
16
|
22
|
18
|
19
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Onyx Therapeutics, Inc. | 71 |
9 |
| Sederma | 245 |
7 |
| Hoffmann-La Roche Inc. | 3267 |
5 |
| Northwestern University | 3276 |
5 |
| Trustees of Tufts College | 819 |
5 |
| Wisconsin Alumni Research Foundation | 3820 |
4 |
| Enanta Pharmaceuticals, Inc. | 422 |
4 |
| Shanghai Lumosa Therapeutics Co., Ltd. | 15 |
4 |
| University of Cincinnati | 833 |
4 |
| viDA Therapeutics Inc. | 16 |
4 |
| Onkure, Inc. | 21 |
4 |
| The Regents of the University of California | 19517 |
3 |
| The Johns Hopkins University | 5533 |
3 |
| Cornell University | 3202 |
3 |
| Escape Therapeutics, Inc. | 28 |
3 |
| Molecular Transfer, Inc. | 32 |
3 |
| Research & Business Foundation Sungkyunkwan University | 1789 |
3 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 806 |
3 |
| ValiRX plc | 3 |
3 |
| INSUSENSE ApS | 22 |
3 |
| Other owners | 149 |